Healthcare-focused private equity firm Avista Healthcare Partners has signed a definitive agreement to acquire sanotact Group GmbH, a Germany-based vitamins and supplements company with operations across global markets. The deal highlights growing investor interest in the fast-expanding preventive healthcare and wellness sector.
The transaction was announced through an official statement released by the companies involved. Belgium-based Damier Group will participate in the acquisition as a strategic co-investor. Existing shareholder FLOTTE Beteiligungen GmbH will also remain invested in the company after the transaction closes.
Sanotact Expands Its Global Reach
Headquartered in Münster, Germany, sanotact develops and manufactures vitamins, minerals, and supplement products. The company also operates a contract development and manufacturing business, supplying products to retail and healthcare partners worldwide.
According to the official announcement, Sanotact distributes its products in more than 80 countries. The company sells products under its own “sanotact” brand and also works with commercial partners through private-label and manufacturing services.
The company has built a strong presence in the European consumer healthcare market, especially in the vitamins, minerals, and supplements category. Its product portfolio includes various health and wellness solutions sold through pharmacies, drugstores, and retail chains.
Avista Sees Long-Term Growth Opportunity
Avista Healthcare Partners said the acquisition supports its strategy of investing in healthcare and consumer wellness businesses with long-term growth potential.
Thompson Dean, Chairman of Avista Healthcare Partners, said Sanotact has developed a strong market position through product quality, innovation, and customer relationships. He added that the company is well-positioned to benefit from increasing consumer demand for preventive healthcare products.
The vitamins and supplements industry has continued to grow as more consumers focus on nutrition, immunity, and everyday wellness. Industry analysts have also noted increasing demand for self-care and health-support products across Europe and international markets.
Existing Investor Will Continue Support
FLOTTE Beteiligungen GmbH, which previously invested in sanotact, will continue as an investor alongside Avista and Damier Group. The company said the new partnership will help support Sanotact’s future expansion plans while maintaining its focus on quality and innovation.
Financial terms of the acquisition were not disclosed. The transaction is expected to close after receiving customary regulatory approvals and meeting standard closing conditions.
Several advisory firms supported the transaction. Alantra served as the exclusive M&A advisor to FLOTTE Beteiligungen, while legal and financial advisors from multiple firms also participated in the deal process.
The acquisition marks another important move in the global healthcare investment market, where private equity firms continue to target companies involved in wellness, nutrition, and consumer health products.
